Searching for non-genetic molecular and imaging PTSD risk and resilience markers: Systematic review of literature and design of the German Armed Forces PTSD biomarker study

Psychoneuroendocrinology

Volumn 51, Issue , 2015, Pages 444-458

  Schmidt, Ulrike ^a   Willmund, Gerd Dieter ^b   Holsboer, Florian ^a   Wotjak, Carsten T ^a   Gallinat, Jürgen ^c   Kowalski, Jens T ^b   Zimmermann, Peter ^b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b German Armed Forces Center of Military Mental Health   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Biomarkers for PTSD; Combat related PTSD; German Armed Forces (Bundeswehr) PTSD biomarker study (Bw BioPTSD); Post trauma PTSD risk markers; Posttraumatic stress disorder; Pre trauma PTSD risk markers; PTSD; Resilience markers for PTSD; Risk markers for PTSD; Vulnerability markers for PTSD

Indexed keywords

4 AMINOBUTYRIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; INTERLEUKIN 8; MOLECULAR MARKER; BIOLOGICAL MARKER;

ARMY; ARTICLE; BLOOD SAMPLING; BRAIN SIZE; COPING BEHAVIOR; CORTICOSTERONE BLOOD LEVEL; DIAGNOSTIC IMAGING; DISEASE MARKER; DISEASE PREDISPOSITION; DNA METHYLATION; FRACTIONAL ANISOTROPY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GERMAN (CITIZEN); HAIR LEVEL; HIPPOCAMPUS; HUMAN; LONGITUDINAL STUDY; META ANALYSIS; MILITARY DEPLOYMENT; MOLECULAR DIAGNOSIS; NEUROIMAGING; POSTTRAUMATIC STRESS DISORDER; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PSYCHOLOGIC ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; BRAIN; COMBAT DISORDERS; PATHOLOGY; PROTECTION; PSYCHOLOGY; SOLDIER; STRESS DISORDERS, POST-TRAUMATIC;

BIOLOGICAL MARKERS; BRAIN; COMBAT DISORDERS; HUMANS; MILITARY PERSONNEL; NEUROIMAGING; PROTECTIVE FACTORS; RESILIENCE, PSYCHOLOGICAL; RISK FACTORS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84920600170     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2014.08.020     Document Type: Article

References (100)

1. Admon R., Leykin D., Lubin G., Engert V., Andrews J., Pruessner J., Hendler T. Stress-induced reduction in hippocampal volume and connectivity with the ventromedial prefrontal cortex are related to maladaptive responses to stressful military service: Hippocampal Deficits Following Military Stress. Hum. Brain Mapp. 2013, 34:2808-2816. 10.1002/hbm.22100.
2. Admon R., Lubin G., Stern O., Rosenberg K., Sela L., Ben-Ami H., Hendler T. Human vulnerability to stress depends on amygdala's predisposition and hippocampal plasticity. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14120-14125. 10.1073/pnas.0903183106.
3. Admon R., Milad M.R., Hendler T. A causal model of post-traumatic stress disorder: disentangling predisposed from acquired neural abnormalities. Trends Cogn. Sci. 2013, 17:337-347. 10.1016/j.tics.2013.05.005.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR 2000, American Psychiatric Association, Washington, DC. 4th ed., text revision.
5. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders: DSM-5 2013, American Psychiatric Association, Washington, DC. 5th ed.
6. Apfel B.A., Otte C., Inslicht S.S., McCaslin S.E., Henn-Haase C., Metzler T.J., Makotkine I., Yehuda R., Neylan T.C., Marmar C.R. Pretraumatic prolonged elevation of salivary MHPG predicts peritraumatic distress and symptoms of post-traumatic stress disorder. J. Psychiatr. Res. 2011, 45:735-741. 10.1016/j.jpsychires.2010.11.016.
7. Baker D.G., Nievergelt C.M., O'Connor D.T. Biomarkers of PTSD: neuropeptides and immune signaling. Neuropharmacology 2012, 62:663-673. 10.1016/j.neuropharm.2011.02.027.
8. Balakathiresan N.S., Chandran R., Bhomia M., Jia M., Li H., Maheshwari R.K. Serum and amygdala microRNA signatures of posttraumatic stress: fear correlation and biomarker potential. J. Psychiatr. Res. 2014, 10.1016/j.jpsychires.2014.05.020.
9. Biomarkers Definitions Working Group Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 2001, 69:89-95. 10.1067/mcp.2001.113989.
10. Bonne O., Brandes D., Gilboa A., Gomori J.M., Shenton M.E., Pitman R.K., Shalev A.Y. Longitudinal MRI study of hippocampal volume in trauma survivors with PTSD. Am. J. Psychiatry 2001, 158:1248-1251.
11. Bonne O., Brandes D., Segman R., Pitman R.K., Yehuda R., Shalev A.Y. Prospective evaluation of plasma cortisol in recent trauma survivors with posttraumatic stress disorder. Psychiatry Res. 2003, 119:171-175.
12. Boscarino J., Kirchner, Hoffman, Erlich Predicting PTSD using the New York Risk Score with genotype data: potential clinical and research opportunities. Neuropsychiatr. Dis. Treat. 2013, 517. 10.2147/NDT.S42422.
13. Bradley B., Westen D., Mercer K.B., Binder E.B., Jovanovic T., Crain D., Wingo A., Heim C. Association between childhood maltreatment and adult emotional dysregulation in a low-income, urban, African American sample: Moderation by oxytocin receptor gene. Dev. Psychopathol. 2011, 23:439-452. 10.1017/S0954579411000162.
14. Brosbe M.S., Hoefling K., Faust J. Predicting posttraumatic stress following pediatric injury: a systematic review. J. Pediatr. Psychol. 2011, 36:718-729. 10.1093/jpepsy/jsq115.
15. Cohen M., Meir T., Klein E., Volpin G., Assaf M., Pollack S. Cytokine levels as potential biomarkers for predicting the development of posttraumatic stress symptoms in casualties of accidents. Int. J. Psychiatry Med. 2011, 42:117-131.
16. Delahanty D.L. Predicting PTSD prospectively based on prior trauma history and immediate biological responses. Ann. N. Y. Acad. Sci. 2006, 1071:27-40. 10.1196/annals.1364.003.
17. Delahanty D.L., Nugent N.R., Christopher N.C., Walsh M. Initial urinary epinephrine and cortisol levels predict acute PTSD symptoms in child trauma victims. Psychoneuroendocrinology 2005, 30:121-128. 10.1016/j.psyneuen.2004.06.004.
18. Delahanty D.L., Raimonde A.J., Spoonster E. Initial posttraumatic urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims. Biol. Psychiatry 2000, 48:940-947.
19. Dias B.G., Ressler K.J. PACAP and the PAC1 receptor in post-traumatic stress disorder. Neuropsychopharmacology 2013, 38:245-246. 10.1038/npp.2012.147.
20. DiGangi J.A., Gomez D., Mendoza L., Jason L.A., Keys C.B., Koenen K.C. Pretrauma risk factors for posttraumatic stress disorder: a systematic review of the literature. Clin. Psychol. Rev. 2013, 33:728-744. 10.1016/j.cpr.2013.05.002.
21. Domschke K. Patho-genetics of posttraumatic stress disorder. Psychiatr. Danub. 2012, 24:267-273.
22. Ehring T., Ehlers A., Cleare A.J., Glucksman E. Do acute psychological and psychobiological responses to trauma predict subsequent symptom severities of PTSD and depression?. Psychiatry Res. 2008, 161:67-75. 10.1016/j.psychres.2007.08.014.
23. Eraly S.A., Nievergelt C.M., Maihofer A.X., Barkauskas D.A., Biswas N., Agorastos A., O'Connor D.T., Baker D.G. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry 2014, 10.1001/jamapsychiatry.2013.4374.
24. Euston D.R., Gruber A.J., McNaughton B.L. The role of medial prefrontal cortex in memory and decision making. Neuron 2012, 76:1057-1070. 10.1016/j.neuron.2012.12.002.
25. Foa E.B., Cashman L., Jaycox L., Perry K. The validation of a self-report measure of posttraumatic stress disorder: the posttraumatic diagnostic scale. Psychol. Assess. 1997, 9:445-451. 10.1037/1040-3590.9.4.445.
26. Gershon A., Sudheimer K., Tirouvanziam R., Williams L.M., O'Hara R. The long-term impact of early adversity on late-life psychiatric disorders. Curr. Psychiatry Rep. 2013, 15. 10.1007/s11920-013-0352-9.
27. Geuze E., van Berckel B.N.M., Lammertsma A.A., Boellaard R., de Kloet C.S., Vermetten E., Westenberg H.G.M. Reduced GABAA benzodiazepine receptor binding in veterans with post-traumatic stress disorder. Mol. Psychiatry 2008, 13:74-83. 10.1038/sj.mp.4002054.
28. Gilbertson M.W., Shenton M.E., Ciszewski A., Kasai K., Lasko N.B., Orr S.P., Pitman R.K. Smaller hippocampal volume predicts pathologic vulnerability to psychological trauma. Nat. Neurosci. 2002, 5:1242-1247. 10.1038/nn958.
29. Gillespie C.F., Phifer J., Bradley B., Ressler K.J. Risk and resilience: genetic and environmental influences on development of the stress response. Depress. Anxiety 2009, 26:984-992. 10.1002/da.20605.
30. Glaser R., Kiecolt-Glaser J.K. Science and society: stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 2005, 5:243-251. 10.1038/nri1571.
31. Glatt S.J., Tylee D.S., Chandler S.D., Pazol J., Nievergelt C.M., Woelk C.H., Baker D.G., Lohr J.B., Kremen W.S., Litz B.T., Tsuang M.T. Marine resiliency study investigators, blood-based gene-expression predictors of PTSD risk and resilience among deployed marines: a pilot study. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2013, 162:313-326. 10.1002/ajmg.b.32167.
32. Golub Y., Kaltwasser S.F., Mauch C.P., Herrmann L., Schmidt U., Holsboer F., Czisch M., Wotjak C.T. Reduced hippocampus volume in the mouse model of Posttraumatic Stress Disorder. J. Psychiatr. Res. 2011, 45:650-659. 10.1016/j.jpsychires.2010.10.014.
33. Guthrie R.M., Bryant R.A. Auditory startle response in firefighters before and after trauma exposure. Am. J. Psychiatry 2005, 162:283-290. 10.1176/appi.ajp.162.2.283.
34. Heinrichs M., Wagner D., Schoch W., Soravia L.M., Hellhammer D.H., Ehlert U. Predicting posttraumatic stress symptoms from pretraumatic risk factors: a 2-year prospective follow-up study in firefighters. Am. J. Psychiatry 2005, 162:2276-2286. 10.1176/appi.ajp.162.12.2276.
35. Hendriksen H., Olivier B., Oosting R.S. From non-pharmacological treatments for post-traumatic stress disorder to novel therapeutic targets. Eur. J. Pharmacol. 2014, 10.1016/j.ejphar.2014.03.031.
36. Herrmann L., Ionescu I.A., Henes K., Golub Y., Wang N.X.R., Buell D.R., Holsboer F., Wotjak C.T., Schmidt U. Long-lasting hippocampal synaptic protein loss in a mouse model of posttraumatic stress disorder. PLOS ONE 2012, 7:e42603. 10.1371/journal.pone.0042603.
37. Inslicht S.S., Otte C., McCaslin S.E., Apfel B.A., Henn-Haase C., Metzler T., Yehuda R., Neylan T.C., Marmar C.R. Cortisol awakening response prospectively predicts peritraumatic and acute stress reactions in police officers. Biol. Psychiatry 2011, 70:1055-1062. 10.1016/j.biopsych.2011.06.030.
38. Ionescu I.A., Dine J., Yen Y.-C., Buell D.R., Herrmann L., Holsboer F., Eder M., Landgraf R., Schmidt U. Intranasally administered neuropeptide S (NPS) exerts anxiolytic effects following internalization into NPS receptor-expressing neurons. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2012, 37:1323-1337. 10.1038/npp.2011.317.
39. Kasai K., Yamasue H., Gilbertson M.W., Shenton M.E., Rauch S.L., Pitman R.K. Evidence for acquired pregenual anterior cingulate gray matter loss from a twin study of combat-related posttraumatic stress disorder. Biol. Psychiatry 2008, 63:550-556. 10.1016/j.biopsych.2007.06.022.
40. Kessler R.C., Sonnega A., Bromet E., Hughes M., Nelson C.B. Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 1995, 52:1048-1060.
41. Klaassens E.R., Giltay E.J., Cuijpers P., van Veen T., Zitman F.G. Adulthood trauma and HPA-axis functioning in healthy subjects and PTSD patients: a meta-analysis. Psychoneuroendocrinology 2012, 37:317-331. 10.1016/j.psyneuen.2011.07.003.
42. Klauke B., Deckert J., Zwanzger P., Baumann C., Arolt V., Pauli P., Reif A., Domschke K. Neuropeptide S receptor gene (NPSR) and life events: G×E effects on anxiety sensitivity and its subdimensions. World J. Biol. Psychiatry 2014, 15:17-25. 10.3109/15622975.2011.646302.
43. Klengel T., Mehta D., Anacker C., Rex-Haffner M., Pruessner J.C., Pariante C.M., Pace T.W.W., Mercer K.B., Mayberg H.S., Bradley B., Nemeroff C.B., Holsboer F., Heim C.M., Ressler K.J., Rein T., Binder E.B. Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat. Neurosci. 2013, 16:33-41. 10.1038/nn.3275.
44. Kremen W.S., Koenen K.C., Afari N., Lyons M.J. Twin studies of posttraumatic stress disorder: differentiating vulnerability factors from sequelae. Neuropharmacology 2012, 62:647-653. 10.1016/j.neuropharm.2011.03.012.
45. Küçükibrahimoğlu E., Saygin M.Z., Çalişkan M., Kaplan O.K., Ünsal C., Gören M.Z. The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression. Eur. J. Clin. Pharmacol. 2009, 65:571-577. 10.1007/s00228-009-0650-7.
46. Kühn S., Gallinat J. Gray matter correlates of posttraumatic stress disorder: a quantitative meta-analysis. Biol. Psychiatry 2013, 73:70-74. 10.1016/j.biopsych.2012.06.029.
47. Leech R., Kamourieh S., Beckmann C.F., Sharp D.J. Fractionating the default mode network: distinct contributions of the ventral and dorsal posterior cingulate cortex to cognitive control. J. Neurosci. 2011, 31:3217-3224. 10.1523/JNEUROSCI.5626-10.2011.
48. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gøtzsche P.C., Ioannidis J.P.A., Clarke M., Devereaux P.J., Kleijnen J., Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009, 6:e1000100. 10.1371/journal.pmed.1000100.
49. Maier T. Post-traumatic stress disorder revisited: deconstructing the A-criterion. Med. Hypotheses 2006, 66:103-106. 10.1016/j.mehy.2005.07.028.
50. Matsuoka Y., Nishi D., Noguchi H., Kim Y., Hashimoto K. Longitudinal changes in serum brain-derived neurotrophic factor in accident survivors with posttraumatic stress disorder. Neuropsychobiology 2013, 68:44-50. 10.1159/000350950.
51. McFarlane A.C., Barton C.A., Yehuda R., Wittert G. Cortisol response to acute trauma and risk of posttraumatic stress disorder. Psychoneuroendocrinology 2011, 36:720-727. 10.1016/j.psyneuen.2010.10.007.
52. McGowan P.O. Epigenomic mechanisms of early adversity and HPA dysfunction: considerations for PTSD research. Front. Psychiatry 2013, 4:110. 10.3389/fpsyt.2013.00110.
53. Mehta D. Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch. Gen. Psychiatry 2011, 68:901. 10.1001/archgenpsychiatry.2011.50.
54. Meyerhoff D.J., Mon A., Metzler T., Neylan T.C. Cortical gamma-aminobutyric acid and glutamate in posttraumatic stress disorder and their relationships to self-reported sleep quality. Sleep 2014, 10.5665/sleep.3654.
55. Miller A.H. Neuroendocrine and immune system interactions in stress and depression. Psychiatr. Clin. North Am. 1998, 21:443-463.
56. Morris M.C., Rao U. Psychobiology of PTSD in the acute aftermath of trauma: integrating research on coping HPA function and sympathetic nervous system activity. Asian J. Psychiatry 2013, 6:3-21. 10.1016/j.ajp.2012.07.012.
57. Ostrowski S.A., Christopher N.C., van Dulmen M.H.M., Delahanty D.L. Acute child and mother psychophysiological responses and subsequent PTSD symptoms following a child's traumatic event. J. Trauma. Stress 2007, 20:677-687. 10.1002/jts.20286.
58. Pervanidou P., Kolaitis G., Charitaki S., Lazaropoulou C., Papassotiriou I., Hindmarsh P., Bakoula C., Tsiantis J., Chrousos G.P. The natural history of neuroendocrine changes in pediatric posttraumatic stress disorder (PTSD) after motor vehicle accidents: progressive divergence of noradrenaline and cortisol concentrations over time. Biol. Psychiatry 2007, 62:1095-1102. 10.1016/j.biopsych.2007.02.008.
59. Pervanidou P., Kolaitis G., Charitaki S., Margeli A., Ferentinos S., Bakoula C., Lazaropoulou C., Papassotiriou I., Tsiantis J., Chrousos G.P. Elevated morning serum interleukin (IL)-6 or evening salivary cortisol concentrations predict posttraumatic stress disorder in children and adolescents six months after a motor vehicle accident. Psychoneuroendocrinology 2007, 32:991-999. 10.1016/j.psyneuen.2007.07.001.
60. Pitman R.K. Clarifying the origin of biological abnormalities in PTSD through the study of identical twins discordant for combat exposure. Ann. N. Y. Acad. Sci. 2006, 1071:242-254. 10.1196/annals.1364.019.
61. Pitman R.K., Gilbertson M.W., Gurvits T.V., May F.S., Lasko N.B., Metzger L.J., Shenton M.E., Yehuda R., Orr S.P. Clarifying the origin of biological abnormalities in PTSD through the study of identical twins discordant for combat exposure. Ann. N. Y. Acad. Sci. 2006, 1071:242-254. Harvard/VA PTSD Twin Study Investigators. 10.1196/annals.1364.019.
62. Pitman R.K., Rasmusson A.M., Koenen K.C., Shin L.M., Orr S.P., Gilbertson M.W., Milad M.R., Liberzon I. Biological studies of post-traumatic stress disorder. Nat. Rev. Neurosci. 2012, 13:769-787. 10.1038/nrn3339.
63. Plantinga L., Bremner J.D., Miller A.H., Jones D.P., Veledar E., Goldberg J., Vaccarino V. Association between posttraumatic stress disorder and inflammation: a twin study. Brain Behav. Immun. 2013, 30:125-132. 10.1016/j.bbi.2013.01.081.
64. Provençal N., Suderman M.J., Guillemin C., Vitaro F., CÔté S.M., Hallett M., Tremblay R.E., Szyf M. Association of childhood chronic physical aggression with a DNA methylation signature in adult human T cells. PLOS ONE 2014, 9:e89839. 10.1371/journal.pone.0089839.
65. Qin L., Wang Z., Sun Y., Wan J., Su S., Zhou Y., Xu J. A preliminary study of alterations in default network connectivity in post-traumatic stress disorder patients following recent trauma. Brain Res. 2012, 1484:50-56. 10.1016/j.brainres.2012.09.029.
66. Rothbaum B.O., Foa E.B., Riggs D.S., Murdock T., Walsh W. A prospective examination of post-traumatic stress disorder in rape victims. J. Trauma. Stress 1992, 5:455-475. 10.1007/BF00977239.
67. Rusiecki J.A., Byrne C., Galdzicki Z., Srikantan V., Chen L., Poulin M., Yan L., Baccarelli A. PTSD and DNA methylation in select immune function gene promoter regions: a repeated measures case-control study of U.S. Military Service Members. Front. Psychiatry 2013, 4. 10.3389/fpsyt.2013.00056.
68. Rusiecki J.A., Chen L., Srikantan V., Zhang L., Yan L., Polin M.L., Baccarelli A. DNA methylation in repetitive elements and post-traumatic stress disorder: a case-control study of US military service members. Epigenomics 2012, 4:29-40. 10.2217/epi.11.116.
69. Sah R., Geracioti T.D. Neuropeptide Y and posttraumatic stress disorder. Mol. Psychiatry 2013, 18:646-655. 10.1038/mp.2012.101.
70. Schmidt U., Herrmann L., Hagl K., Novak B., Huber C., Holsboer F., Wotjak C.T., Buell D.R. Therapeutic action of fluoxetine is associated with a reduction in prefrontal cortical miR-1971 expression levels in a mouse model of posttraumatic stress disorder. Front. Psychiatry 2013, 4:66. 10.3389/fpsyt.2013.00066.
71. Schmidt U., Holsboer F., Rein T. Epigenetic aspects of posttraumatic stress disorder. Dis. Markers 2011, 30:77-87. 10.3233/DMA-2011-0749.
72. Schmidt U., Kaltwasser S.F., Wotjak C.T. Biomarkers in posttraumatic stress disorder: overview and implications for future research. Dis. Markers 2013, 35:43-54. 10.1155/2013/835876.
73. Schmidt U., Wagner H., Miethke T. CpG-DNA upregulates the major acute-phase proteins SAA and SAP. Cell. Microbiol. 1999, 1:61-67. 10.1046/j.1462-5822.1999.00007.x.
74. Searcy C.P., Bobadilla L., Gordon W.A., Jacques S., Elliott L. Pharmacological prevention of combat-related PTSD: a literature review. Mil. Med. 2012, 177:649-654.
75. Seckl J.R., Meaney M.J. Glucocorticoid "programming" and PTSD risk. Ann. N. Y. Acad. Sci. 2006, 1071:351-378. 10.1196/annals.1364.027.
76. Segman R.H., Shefi N., Goltser-Dubner T., Friedman N., Kaminski N., Shalev A.Y. Peripheral blood mononuclear cell gene expression profiles identify emergent post-traumatic stress disorder among trauma survivors. Mol. Psychiatry 2005, 10. pp. 500-513, 425. 10.1038/sj.mp.4001636.
77. Sexton C.E., Mackay C.E., Ebmeier K.P. A systematic review and meta-analysis of magnetic resonance imaging studies in late-life depression. Am. J. Geriatr. Psychiatry Off. J. Am. Assoc. Geriatr. Psychiatry 2013, 21:184-195. 10.1016/j.jagp.2012.10.019.
78. Shalev A.Y., Videlock E.J., Peleg T., Segman R., Pitman R.K., Yehuda R. Stress hormones and post-traumatic stress disorder in civilian trauma victims: a longitudinal study. Part I. HPA axis responses. Int. J. Neuropsychopharmacol. Off. Sci. J. Coll. Int. Neuropsychopharmacol. CINP 2008, 11:365-372. 10.1017/S1461145707008127.
79. Shin L.M., Bush G., Milad M.R., Lasko N.B., Brohawn K.H., Hughes K.C., Macklin M.L., Gold A.L., Karpf R.D., Orr S.P., Rauch S.L., Pitman R.K. Exaggerated activation of dorsal anterior cingulate cortex during cognitive interference: a monozygotic twin study of posttraumatic stress disorder. Am. J. Psychiatry 2011, 168. 10.1176/appi.ajp.2011.09121812.
80. Shin L.M., Lasko N.B., Macklin M.L., Karpf R.D., Milad M.R., Orr S.P., Goetz J.M., Fischman A.J., Rauch S.L., Pitman R.K. Resting metabolic activity in the cingulate cortex and vulnerability to posttraumatic stress disorder. Arch. Gen. Psychiatry 2009, 66:1099. 10.1001/archgenpsychiatry.2009.138.
81. Skeffington P.M., Rees C.S., Kane R. The primary prevention of PTSD: a systematic review. J. Trauma Dissoc. 2013, 14:404-422. 10.1080/15299732.2012.753653.
82. Spivak B., Maayan R., Kotler M., Mester R., Gil-Ad I., Shtaif B., Weizman A. Elevated circulatory level of GABA(A) - antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder. Psychol. Med. 2000, 30:1227-1231.
83. Stander V.A., Thomsen C.J., Highfill-McRoy R.M. Etiology of depression comorbidity in combat-related PTSD: a review of the literature. Clin. Psychol. Rev. 2014, 34:87-98. 10.1016/j.cpr.2013.12.002.
84. Sun Y., Wang Z., Ding W., Wan J., Zhuang Z., Zhang Y., Liu Y., Zhou Y., Xu J. Alterations in white matter microstructure as vulnerability factors and acquired signs of traffic accident-induced PTSD. PLOS ONE 2013, 8:e83473. 10.1371/journal.pone.0083473.
85. Uddin M., Aiello A.E., Wildman D.E., Koenen K.C., Pawelec G., de Los Santos R., Goldmann E., Galea S. Epigenetic and immune function profiles associated with posttraumatic stress disorder. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:9470-9475. 10.1073/pnas.0910794107.
86. Vaiva G., Boss V., Ducrocq F., Fontaine M., Devos P., Brunet A., Laffargue P., Goudemand M., Thomas P. Relationship between posttrauma GABA plasma levels and PTSD at 1-year follow-up. Am. J. Psychiatry 2006, 163:1446-1448. 10.1176/appi.ajp.163.8.1446.
87. Vaiva G., Thomas P., Ducrocq F., Fontaine M., Boss V., Devos P., Rascle C., Cottencin O., Brunet A., Laffargue P., Goudemand M. Low posttrauma GABA plasma levels as a predictive factor in the development of acute posttraumatic stress disorder. Biol. Psychiatry 2004, 55:250-254.
88. Van Zuiden M., Geuze E., Willemen H.L.D.M., Vermetten E., Maas M., Amarouchi K., Kavelaars A., Heijnen C.J. Glucocorticoid receptor pathway components predict posttraumatic stress disorder symptom development: a prospective study. Biol. Psychiatry 2012, 71:309-316. 10.1016/j.biopsych.2011.10.026.
89. Van Zuiden M., Geuze E., Willemen H.L.D.M., Vermetten E., Maas M., Heijnen C.J., Kavelaars A. Pre-existing high glucocorticoid receptor number predicting development of posttraumatic stress symptoms after military deployment. Am. J. Psychiatry 2011, 168:89-96. 10.1176/appi.ajp.2010.10050706.
90. Van Zuiden M., Heijnen C.J., Maas M., Amarouchi K., Vermetten E., Geuze E., Kavelaars A. Glucocorticoid sensitivity of leukocytes predicts PTSD, depressive and fatigue symptoms after military deployment: a prospective study. Psychoneuroendocrinology 2012, 37:1822-1836. 10.1016/j.psyneuen.2012.03.018.
91. Van Zuiden M., Kavelaars A., Rademaker A.R., Vermetten E., Heijnen C.J., Geuze E. A prospective study on personality and the cortisol awakening response to predict posttraumatic stress symptoms in response to military deployment. J. Psychiatr. Res. 2011, 45:713-719. 10.1016/j.jpsychires.2010.11.013.
92. Videlock E.J., Peleg T., Segman R., Yehuda R., Pitman R.K., Shalev A.Y. Stress hormones and post-traumatic stress disorder in civilian trauma victims: a longitudinal study. Part II. The adrenergic response. Int. J. Neuropsychopharmacol. Off. Sci. J. Coll. Int. Neuropsychopharmacol. CINP 2008, 11:373-380. 10.1017/S1461145707008139.
93. Walsh K., Nugent N.R., Kotte A., Amstadter A.B., Wang S., Guille C., Acierno R., Kilpatrick D.G., Resnick H.S. Cortisol at the emergency room rape visit as a predictor of PTSD and depression symptoms over time. Psychoneuroendocrinology 2013, 38:2520-2528. 10.1016/j.psyneuen.2013.05.017.
94. Wittchen H.-U., Schönfeld S., Kirschbaum C., Thurau C., Trautmann S., Steudte S., Klotsche J., Höfler M., Hauffa R., Zimmermann P. Traumatic experiences and posttraumatic stress disorder in soldiers following deployment abroad: how big is the hidden problem?. Dtsch. Ärztebl. Int. 2012, 109:559-568. 10.3238/arztebl.2012.0559.
95. Yehuda R., Flory J.D. Differentiating biological correlates of risk, PTSD, and resilience following trauma exposure. J. Trauma. Stress 2007, 20:435-447. 10.1002/jts.20260.
96. Yehuda R., Koenen K.C., Galea S., Flory J.D. The role of genes in defining a molecular biology of PTSD. Dis. Markers 2011, 30:67-76. 10.3233/DMA-2011-0794.
97. Yehuda R., Neylan T.C., Flory J.D., McFarlane A.C. The use of biomarkers in the military: from theory to practice. Psychoneuroendocrinology 2013, 38:1912-1922. 10.1016/j.psyneuen.2013.06.009.
98. Yehuda R., Resnick H.S., Schmeidler J., Yang R.K., Pitman R.K. Predictors of cortisol and 3-methoxy-4-hydroxyphenylglycol responses in the acute aftermath of rape. Biol. Psychiatry 1998, 43:855-859.
99. Zhou J., Nagarkatti P., Zhong Y., Ginsberg J.P., Singh N.P., Zhang J., Nagarkatti M. Dysregulation in microRNA expression is associated with alterations in immune functions in combat veterans with post-traumatic stress disorder. PLOS ONE 2014, 9:e94075. 10.1371/journal.pone.0094075.
100. Zhou Y., Wang Z., Qin L., Wan J., Sun Y., Su S., Ding W., Xu J. Early altered resting-state functional connectivity predicts the severity of post-traumatic stress disorder symptoms in acutely traumatized subjects. PLOS ONE 2012, 7:e46833. 10.1371/journal.pone.0046833.